Archer Investment Corporation’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09K | Hold |
248
| – | – | ﹤0.01% | 839 |
|
|
2025
Q1 | $5.08K | Hold |
248
| – | – | ﹤0.01% | 815 |
|
|
2024
Q4 | $5.61K | Hold |
248
| – | – | ﹤0.01% | 808 |
|
|
2024
Q3 | $6.1K | Hold |
248
| – | – | ﹤0.01% | 771 |
|
|
2024
Q2 | $5.73K | Hold |
248
| – | – | ﹤0.01% | 761 |
|
|
2024
Q1 | $5.97K | Hold |
248
| – | – | ﹤0.01% | 743 |
|
|
2023
Q4 | $5.71K | Hold |
248
| – | – | ﹤0.01% | 762 |
|
|
2023
Q3 | $5.05K | Sell |
248
-752
| -75% | -$15.3K | ﹤0.01% | 747 |
|
|
2023
Q2 | $23.4K | Hold |
1,000
| – | – | 0.01% | 485 |
|
|
2023
Q1 | $23.3K | Hold |
1,000
| – | – | 0.01% | 465 |
|
|
2022
Q4 | $25.2K | Hold |
1,000
| – | – | 0.01% | 438 |
|
|
2022
Q3 | $26.4K | Hold |
1,000
| – | – | 0.01% | 420 |
|
|
2022
Q2 | $28.9K | Hold |
1,000
| – | – | 0.01% | 416 |
|
|
2022
Q1 | $33.8K | Hold |
1,000
| – | – | 0.01% | 410 |
|
|
2021
Q4 | $43.8K | Hold |
1,000
| – | – | 0.01% | 383 |
|
|
2021
Q3 | $50.7K | Hold |
1,000
| – | – | 0.02% | 356 |
|
|
2021
Q2 | $52K | Hold |
1,000
| – | – | 0.02% | 322 |
|
|
2021
Q1 | $45.7K | Sell |
1,000
-6,000
| -86% | -$274K | 0.02% | 355 |
|
|
2020
Q4 | $322K | Hold |
7,000
| – | – | 0.15% | 150 |
|
|
2020
Q3 | $273K | Hold |
7,000
| – | – | 0.14% | 144 |
|
|
2020
Q2 | $266K | Sell |
7,000
-2,000
| -22% | -$75.9K | 0.15% | 139 |
|
|
2020
Q1 | $242K | Buy |
+9,000
| New | +$242K | 0.16% | 139 |
|